(Q33898364)

29 July 2017

1 reference

title

On the pharmacotherapy of obsessive-compulsive disorder: is a consensus possible? (English)

1 reference

obsessive-compulsive disorder

29 July 2017

0 references

1 reference

C Todorov

1

1 reference

29 July 2017

M H Freeston

series ordinal

2

1 reference

29 July 2017

F Borgeat

series ordinal

3

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

Canadian Journal of Psychiatry

29 July 2017

published in

1 reference

29 July 2017

volume

45

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

257-262

1 reference

Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F070674370004500304

Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370004500304

Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370004500304

Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370004500304

Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370004500304

Placebo effects. Issues for clinical practice in psychiatry and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370004500304

10.1177/070674370004500304

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference